# The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients

**Authors:** Jinfu Wu, Hang Sun, Yiyang Zhao, Lian Lian, Hongsheng Bian, Yong Guo, Dan Li, Lili Huang

PMC · DOI: 10.3389/fphar.2025.1538837 · Frontiers in Pharmacology · 2025-01-28

## TL;DR

This study identifies key compounds in Kai-Xin-San that improve memory in a fly model of Alzheimer's disease.

## Contribution

The paper establishes a spectrum-effect relationship and identifies active ingredients in Kai-Xin-San for Alzheimer's treatment.

## Key findings

- Eight active components in Kai-Xin-San were identified, including polygalaxanthone III and ginsenosides.
- Kai-Xin-San treatment improved memory performance in Aβ42 transgenic drosophila.
- Five compounds showed a positive correlation with memory improvement in the olfactory experiment.

## Abstract

This study aims to establish the fingerprint spectra of Kai-Xin-San (KXS) and investigate its spectrum-effect relationship in treating Alzheimer’s disease (AD).

Initially, the fingerprints of 15 batches of KXS were established and analyzed using HPLC, with the method’s precision, stability, and repeatability thoroughly evaluated. Subsequently, the effects of the 15 batches of KXS were assessed in an olfactory escape memory experiment, utilizing Aβ42 transgenic drosophila as a model. Finally, the spectrum-effect relationship between the KXS fingerprint and memory improvement was analyzed, with the active ingredients subjected to validation testing.

The results identified seventeen common peaks in the fingerprint, and eight active components were determined: polygalaxanthone III, 3-6-disinapoylsucrose, ginsenoside Rg1, ginsenoside Rb1, β-asarone, α-asarone, dehydrotumulosic acid, and dehydropachymic acid. Treatment with KXS (1%, for 4 days) significantly enhanced the performance index of Aβ42 flies in the olfactory experiment. Both spectrum-effect analysis and validation tests indicated that polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone were positively correlated with the performance index and improved the performance index in the olfactory experiment. The HPLC fingerprint method for KXS demonstrated excellent precision, accuracy, and reproducibility, making it suitable for quality evaluation and control of KXS. Polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone are identified as potential active ingredients of KXS for anti-AD effects.

These findings provide an experimental basis for developing new drugs based on KXS and its active ingredient combinations.

## Linked entities

- **Chemicals:** polygalaxanthone III (PubChem CID 11169063), 3-6-disinapoylsucrose (PubChem CID 391123), ginsenoside Rg1 (PubChem CID 432116), ginsenoside Rb1 (PubChem CID 9898279), β-asarone (PubChem CID 17903), α-asarone (PubChem CID 636822), dehydrotumulosic acid (PubChem CID 15225964), dehydropachymic acid (PubChem CID 12133289)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Drosophila (taxon 7215)

## Full-text entities

- **Diseases:** AD (MESH:D000544)
- **Chemicals:** dehydrotumulosic acid (MESH:C102488), dehydropachymic acid (MESH:C585138), ginsenoside Rg1 (MESH:C035054), ginsenoside Rb1 (MESH:C442759), alpha-asarone (MESH:C012195), 3-6-disinapoylsucrose (MESH:C546986), Polygalaxanthone III (MESH:C092101)
- **Species:** Drosophila melanogaster (fruit fly, species) [taxon 7227]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11811076/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11811076/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC11811076/full.md

---
Source: https://tomesphere.com/paper/PMC11811076